Harpreet Singh, MD
Pain Medicine · Parma, OHNPI 1770804247
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 58.9% of the total. Reporting peaked in 2021 at $1,189 and has fallen 77.0% since, to $273 in 2025. That places this record below the midpoint for pain medicine clinicians in OH, where the typical reported total is $1,899.
Across 36 payments — averaging $55.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Biotronik Inc.$194
- Globus Medical$157
- Relievant Medsystems, Inc.$138
- Johnson & Johnson$131
- AbbVie$52
- plus $155 from 5 others
What the payments were for
- Travel & lodging$1,02651%
- Food & beverage$98549%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 8 | $1,184 |
| Biotronik Inc. | 2 | $194 |
| Globus Medical | 2 | $157 |
| Relievant Medsystems, Inc. | 12 | $138 |
| Johnson & Johnson | 1 | $131 |
| AbbVie | 3 | $52 |
| Nalu Medical, Inc. | 3 | $50 |
| MML US, Inc. | 2 | $48 |
| GRT US Holding, Inc. | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $20 |
| Tonix Medicines, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IOVERA SYSTEM$1,026
- Edora 8 DR-T$166
- BioMonitor$166
- Acticor 7 VR-T DX$166
- Rivacor 7 DR-T$166
- Monarch Platform$131
- Senza$127
How this compares
$2,011 in reported general payments places this provider in the 50th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 13 | $6,688 |
| OxycontinOxycodone Hcl | 13 | $6,668 |
| Pregabalin | 238 | $6,218 |
| Gabapentin | 398 | $5,920 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 204 | $3,962 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 220 | $3,915 |
| Tramadol Hcl | 217 | $1,855 |
| Cyclobenzaprine Hcl | 87 | $1,411 |
| Lidocaine | 22 | $1,299 |
| Celecoxib | 59 | $1,122 |
| Naloxone Hcl | 21 | $1,088 |
| Oxycodone Hcl | 84 | $754 |
| Tizanidine Hcl | 75 | $705 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 45 | $486 |
| Topiramate | 57 | $341 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Parma
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.